• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡相关的 CPT1A 和 GDF15 基因多态性是肺腺癌的危险因素:一项病例对照研究。

Ferroptosis related CPT1A and GDF15 gene polymorphisms are risk factors for lung adenocarcinoma: A case-control study.

机构信息

Respiratory department, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Science/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

Respiratory department, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Science/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

出版信息

Gene. 2025 Jan 15;933:149002. doi: 10.1016/j.gene.2024.149002. Epub 2024 Oct 12.

DOI:10.1016/j.gene.2024.149002
PMID:39401734
Abstract

BACKGROUND

Ferroptosis is not only a consequence of inflammation, but also a dynamic process. Recent bioinformatics analysis suggests that ferroptosis related genes might be associated with lung adenocarcinoma (LUAD). CPT1A and GDF15 are critical for the process of ferroptosis and development of inflammation; however, little study focused on the mutation level of these genes in patients with LUAD.

METHODS

The candidate SNPs in CPT1A and GDF15 were genotyped in 320 pairs of LUAD patients and controls using Mass ARRAY platform. Moreover, the different expression of CPT1A and GDF15 in LUAD cases and healthy controls were validated by qRT-PCR and ELISA.

RESULTS

The rs80356779 G > A, rs3019594 C > T, rs888663 T > G and rs4808793 G > C all exhibited an increased risk of the disease (p < 0.05). Moreover, the rs80356779-GA, rs3019594-TT, rs888663-TG and rs4808793-CC genotypes were all related to different levels of increase in LUAD risk (p < 0.05). Genetic model results showed that rs80356779 G > A, rs888663 T > G and rs4808793 G > C were associated with LUAD susceptibility under dominant and additive models (p < 0.05), while rs3019594 C > T was correlated with an elevated risk of the disease in all three models (p < 0.05). Additionally, patients with rs80356779 G > A and rs3019594 C > T exhibited lower expression and serum concentration of CPT1A compared with wile types, and patients with rs888663 T > G and rs4808793 G > C exhibited higher serum and expression level of GDF15.

CONCLUSION

The results provided new clues for the role of ferroptosis in LUAD and new potential targets for screening of susceptible population.

摘要

背景

铁死亡不仅是炎症的结果,也是一个动态的过程。最近的生物信息学分析表明,铁死亡相关基因可能与肺腺癌(LUAD)有关。CPT1A 和 GDF15 是铁死亡过程和炎症发展的关键,但很少有研究关注这些基因在 LUAD 患者中的突变水平。

方法

使用 Mass ARRAY 平台对 320 对 LUAD 患者和对照者的 CPT1A 和 GDF15 候选 SNP 进行基因分型。此外,通过 qRT-PCR 和 ELISA 验证 LUAD 病例和健康对照者中 CPT1A 和 GDF15 的不同表达。

结果

rs80356779G>A、rs3019594C>T、rs888663T>G 和 rs4808793G>C 均增加了疾病风险(p<0.05)。此外,rs80356779-GA、rs3019594-TT、rs888663-TG 和 rs4808793-CC 基因型均与 LUAD 风险的不同水平增加有关(p<0.05)。遗传模型结果表明,rs80356779G>A、rs888663T>G 和 rs4808793G>C 与显性和加性模型下的 LUAD 易感性相关(p<0.05),而 rs3019594C>T 在所有三种模型中均与疾病风险升高相关(p<0.05)。此外,与野生型相比,rs80356779G>A 和 rs3019594C>T 患者的 CPT1A 表达和血清浓度较低,而 rs888663T>G 和 rs4808793G>C 患者的 GDF15 血清和表达水平较高。

结论

这些结果为铁死亡在 LUAD 中的作用提供了新的线索,并为筛选易感人群提供了新的潜在靶点。

相似文献

1
Ferroptosis related CPT1A and GDF15 gene polymorphisms are risk factors for lung adenocarcinoma: A case-control study.铁死亡相关的 CPT1A 和 GDF15 基因多态性是肺腺癌的危险因素:一项病例对照研究。
Gene. 2025 Jan 15;933:149002. doi: 10.1016/j.gene.2024.149002. Epub 2024 Oct 12.
2
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.一种新的与铁死亡相关的基因模型用于肺腺癌的预后预测。
BMC Pulm Med. 2021 Jul 13;21(1):229. doi: 10.1186/s12890-021-01588-2.
3
Potential Impacts of Promoter Polymorphisms on the Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan.台湾地区启动子多态性对非小细胞肺癌突变状态和进展的潜在影响。
Genes (Basel). 2021 Mar 17;12(3):427. doi: 10.3390/genes12030427.
4
Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.肺腺癌中自噬依赖性铁死亡相关基因 FANCD2 的综合分析。
BMC Cancer. 2022 Mar 2;22(1):225. doi: 10.1186/s12885-022-09314-9.
5
A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.铁死亡相关基因特征可预测肺腺癌患者的总生存期。
Future Oncol. 2021 Apr;17(12):1533-1544. doi: 10.2217/fon-2020-1113. Epub 2021 Jan 12.
6
Ferroptosis-related genes DUOX1 and HSD17B11 affect tumor microenvironment and predict overall survival of lung adenocarcinoma patients.亚铁死亡相关基因 DUOX1 和 HSD17B11 影响肺腺癌患者的肿瘤微环境并预测其总生存期。
Medicine (Baltimore). 2024 May 31;103(22):e38322. doi: 10.1097/MD.0000000000038322.
7
FKBP3, a poor prognostic indicator, promotes the progression of LUAD via regulating ferroptosis and immune infiltration.FKBP3,一种预后不良的指标,通过调节铁死亡和免疫浸润促进 LUAD 的进展。
Medicine (Baltimore). 2024 Jun 28;103(26):e38606. doi: 10.1097/MD.0000000000038606.
8
Identification of novel pQTL-SNPs associated with lung adenocarcinoma risk: A multi-stage study.鉴定与肺腺癌风险相关的新型 pQTL-SNPs:一项多阶段研究。
Cancer Med. 2024 Sep;13(17):e70247. doi: 10.1002/cam4.70247.
9
Ferroptosis-Related Gene GCLC Is a Novel Prognostic Molecular and Correlates with Immune Infiltrates in Lung Adenocarcinoma.铁死亡相关基因GCLC是一种新型的预后分子,与肺腺癌中的免疫浸润相关。
Cells. 2022 Oct 25;11(21):3371. doi: 10.3390/cells11213371.
10
Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment.环状 RNA BBS9 作为肺腺癌的早期诊断生物标志物:直接与 IFIT3 相互作用调节肿瘤免疫微环境。
Front Immunol. 2024 Jul 19;15:1344954. doi: 10.3389/fimmu.2024.1344954. eCollection 2024.

引用本文的文献

1
Association of macrophage migration-inhibitory factor gene and growth differentiation factor 15 gene polymorphisms and their circulating levels with respiratory distress syndrome among preterm neonates.巨噬细胞移动抑制因子基因和生长分化因子15基因多态性及其循环水平与早产儿呼吸窘迫综合征的关联
Clin Exp Pediatr. 2025 Sep;68(9):680-689. doi: 10.3345/cep.2025.00416. Epub 2025 Apr 1.